Form 4 Filing by Urist Marshall

This filing details a Form 4 submission by Urist Marshall, EVP, Research & Investments at Royalty Pharma plc. On September 28, 2026, Marshall disposed of 4,126 Class A Ordinary Shares at a price of $57.88 per share, resulting in 4,126 shares remaining in the post-transaction holdings. The filing also notes that Marshall and associated entities hold additional interests, including limited partnership interests exchangeable into a significant number of Class A Ordinary Shares. All transactions were executed under a pre-established 10b5-1 trading plan. Marshall